Pharma Global

Global Pharma, a subsidiary of Dubai Investments PJSC, is a leading pharmaceutical company based in Dubai, United Arab Emirates. Established in 1998, the company operates two state-of-the-art manufacturing facilities that produce a wide range of generic and branded pharmaceutical products across therapeutic areas such as cardiovascular, metabolic, and anti-infective health. The company gained significant international attention when Sanofi acquired a majority stake in 2014 to bolster its regional presence, before Dubai Investments repurchased the stake in 2019 to take full ownership. Global Pharma serves as a critical manufacturing hub in the Middle East, exporting to over 20 countries and maintaining high-quality standards compliant with international GMP regulations. Its portfolio includes several market-leading generics, and it continues to expand through strategic partnerships and new product development.